BNP Paribas Financial Markets’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26
| Closed | -$7.49K | – | 3345 |
|
|
2023
Q1 | $7.49K | Sell |
26
-737
| -97% | -$212K | ﹤0.01% | 2933 |
|
|
2022
Q4 | $199K | Buy |
763
+6
| +0.8% | +$1.57K | ﹤0.01% | 2347 |
|
|
2022
Q3 | $203K | Sell |
757
-3
| -0.4% | -$803 | ﹤0.01% | 2787 |
|
|
2022
Q2 | $254K | Sell |
760
-765
| -50% | -$256K | ﹤0.01% | 2367 |
|
|
2022
Q1 | $933K | Hold |
1,525
| – | – | ﹤0.01% | 1858 |
|
|
2021
Q4 | $926K | Buy |
1,525
+768
| +101% | +$466K | ﹤0.01% | 2070 |
|
|
2021
Q3 | $742K | Hold |
757
| – | – | ﹤0.01% | 2011 |
|
|
2021
Q2 | $1.13M | Hold |
757
| – | – | ﹤0.01% | 1610 |
|
|
2021
Q1 | $2.04M | Hold |
757
| – | – | ﹤0.01% | 1260 |
|
|
2020
Q4 | $1.49M | Hold |
757
| – | – | ﹤0.01% | 1247 |
|
|
2020
Q3 | $2.04M | Hold |
757
| – | – | ﹤0.01% | 1076 |
|
|
2020
Q2 | $2.15M | Buy |
757
+385
| +103% | +$1.09M | ﹤0.01% | 1046 |
|
|
2020
Q1 | $994K | Buy |
+372
| New | +$994K | ﹤0.01% | 1420 |
|